Shares of Envista Holdings Corporation (NYSE:NVST – Get Free Report) have earned a consensus rating of “Hold” from the seventeen brokerages that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $26.50.
NVST has been the topic of a number of research analyst reports. Morgan Stanley set a $19.00 price target on shares of Envista in a report on Friday. Wall Street Zen upgraded shares of Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th. Mizuho set a $24.00 price target on shares of Envista and gave the company a “neutral” rating in a research note on Tuesday, January 20th. Weiss Ratings reiterated a “sell (d)” rating on shares of Envista in a report on Monday, December 29th. Finally, Wells Fargo & Company raised their price objective on Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a report on Friday.
View Our Latest Stock Analysis on NVST
Envista Trading Up 18.0%
Envista (NYSE:NVST – Get Free Report) last issued its quarterly earnings results on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. The firm had revenue of $750.60 million during the quarter, compared to analyst estimates of $680.26 million. Envista had a return on equity of 6.55% and a net margin of 1.73%.Envista’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same period last year, the company earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, equities analysts forecast that Envista will post 1 EPS for the current year.
More Envista News
Here are the key news stories impacting Envista this week:
- Positive Sentiment: Q4 results beat expectations — Envista reported $0.38 EPS vs. $0.32 consensus and revenue of $750.6M versus ~ $680M est., with revenue up ~15% year-over-year. Strong results are the primary driver of the move higher. Envista Reports Fourth Quarter 2025 Results
- Positive Sentiment: Management raised FY‑2026 EPS guidance to $1.35–$1.45 vs. consensus ~ $1.27 — the stronger outlook (and beat + guidance combo) is supportive of the rally and suggests better-than-expected near-term growth. Press Release / Slide Deck
- Neutral Sentiment: Earnings materials and call transcripts are available for deeper read — the conference call transcript and slide deck provide management commentary on drivers (product mix, geographic trends, margins) that investors should review to judge sustainability. Earnings Call Transcript Earnings Presentation
- Neutral Sentiment: Wall‑street writeups and snapshots (Zacks, Yahoo, Investing) highlight the beat and value/Growth characteristics — useful for screening but not new catalysts by themselves. Zacks Q4 Metrics
- Negative Sentiment: Analyst targets still imply downside — JPMorgan and Wells Fargo both raised targets to $26 but kept neutral/equal‑weight ratings; those $26 targets sit below the current market level, which could cap upside or prompt caution once headline momentum fades. Benzinga – JPMorgan Benzinga – Wells Fargo
Institutional Trading of Envista
A number of hedge funds have recently added to or reduced their stakes in NVST. Farther Finance Advisors LLC increased its position in Envista by 317.6% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after purchasing an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd boosted its stake in shares of Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares in the last quarter. Allworth Financial LP increased its holdings in Envista by 75.4% during the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares in the last quarter. Finally, IFP Advisors Inc lifted its holdings in Envista by 102.9% during the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after buying an additional 1,071 shares during the period.
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
See Also
- Five stocks we like better than Envista
- The buying spree that no one is talking about
- Virtually Limitless Energy
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
